Recursion Pharma

$9.03 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Recursion Pharma

Recursion Pharmaceuticals, Inc. operates as a bio-technology company. The Company combines artificial intelligence with automation to conduct experimental biology for testing compounds of cellular disease models in parallel. Recursion Pharmaceuticals serves customers worldwide.

Stock Analysis

last close $8.85
1-mo return 23.8%
3-mo return 24.3%
avg daily vol. 1.25M
52-week high 42.81
52-week low 4.92
market cap. $1.4B
forward pe -
annual div. -
roe -164.1%
ltg forecast 15.9%
dividend yield -
annual rev. $13M
inst own. 77%
baraka

Subscribe now for daily local and international financial news

Subscribe